Search results - 93 results
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
cervical precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES: The VALHUDES protocol is designed as a diagnostic test accuracy study that ...
Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.
diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. VALGENT is designed to assess ...
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of ...
Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel.
Human papillomavirus (HPV) testing is being increasingly incorporated into cervical cancer screening. VALGENT (VAL idation of HPV GEN otyping Tests) is a framework designed to evaluate the clinical ...
Defining optimal triage strategies for hrHPV screen positive women- an evaluation of HPV 16/18 genotyping, cytology and p16/Ki-67 cyto-immunochemistry.
Govan, Lynn; Black, Janice; Palmer, Tim; Arbyn, Marc Source: Cancer Epidemiol Biomarkers Prev (2017) Abstract: BACKGROUND: Several options for the triage of high-risk HPV screen positive (hrHPV+) women ...
Role of mucosal high-risk human papillomavirus types in head and neck cancers in central India.
and Neck Neoplasms Humans India Male middle aged Papillomaviridae Papillomavirus Infections Abstract: Mucosal high-risk (HR) human papillomaviruses (HPV) cause a subset of head and neck cancers (HNC). ...
Development and validation of a protocol for optimizing the use of paraffin blocks in molecular epidemiological studies: The example from the HPV-AHEAD study.
Lucas, Eric; Anantharaman, Devasena; Gheit, Tarik; Castellsagué, Xavier; Pawlita, Michael; de Sanjosé, Silvia; Alemany, Laia; Tommasino, Massimo; M. Arbyn; Cindy Simoens; HPV-AHEAD study group Source: PLoS ...
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.
Human papillomaviruses (HPV s) are the necessary cause of most cervical cancers, a large proportion of other anogenital cancers, and a subset of oropharyngeal cancers. The knowledge about HPV has led to ...
Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Squamous Intraepithelial Lesions of the Cervix Uterine Cervical Neoplasms Vaginal Smears Abstract: BACKGROUND: In 2014, liquid-based cytology with HPV triage replaced conventional cytology. The aim of our ...
HPV-based cervical cancer screening- facts, fiction, and misperceptions.
HPV-based cervical cancer screening is more effective than cytology-based screening. A pooled analysis of long-term follow-up data from these trials has shown reduced cervical cancer mortality in women ...